Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide in EBV-associated solid tumors
NCT03494634Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in solid tumor, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03494634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03494634.